{
    "2021-07-12": [
        [
            {
                "time": "2023-10-01",
                "original_text": "医药行业一周观察：板块大幅调整，如何看待创新药和CXO的未来",
                "features": {
                    "keywords": [
                        "医药",
                        "创新药",
                        "CXO",
                        "板块调整"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-02",
                "original_text": "A股收盘综述：题材股多点开花，市场释放出近一年来最强量能",
                "features": {
                    "keywords": [
                        "A股",
                        "题材股",
                        "量能"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-03",
                "original_text": "CRO概念持续回暖，机构：新政释放资源，利好行业长期发展",
                "features": {
                    "keywords": [
                        "CRO",
                        "新政",
                        "行业长期发展"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "医药行业周报：CDE发布临床研发指导原则 加速创新药及CXO行业结构化进程",
                "features": {
                    "keywords": [
                        "医药",
                        "CDE",
                        "临床研发",
                        "创新药",
                        "CXO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "公司研究：「凯莱英（002821）」高瓴豪掷10亿CDMO",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "高瓴资本",
                        "CDMO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CDMO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-06",
                "original_text": "医药生物行业：十四五开启血制品新成长周期 重点推荐天坛生物、博雅生物等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "十四五",
                        "血制品",
                        "天坛生物",
                        "博雅生物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-07",
                "original_text": "CXO板块大幅攀升，康龙化成直线拉升逾5%",
                "features": {
                    "keywords": [
                        "CXO",
                        "康龙化成",
                        "股价拉升"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}